SomaLogic

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.

Type
Private
HQ
Boulder, US
Founded
2000
Employees
179 (est)+4%
SomaLogic was founded in 2000 and is headquartered in Boulder, US

Key People at SomaLogic

Stephen A. Williams

Stephen A. Williams

Chief Medical Officer
Nicholas A. Saccomano

Nicholas A. Saccomano

Chief Technology Officer
Scott Kothlow

Scott Kothlow

CFO
Nebojsa Janjic

Nebojsa Janjic

Chief Science Officer
Larry Gold

Larry Gold

Chairman and CEO

SomaLogic Locations

Boulder, US

SomaLogic Metrics

SomaLogic Summary

Founding Date

2000

Total Funding

$180 M

Latest funding size

$60.5 M

Time since last funding

9 months

Investors

SomaLogic's latest funding round of $60.5 M was in March 2016. In total, SomaLogic has raised $180 M.

SomaLogic Online Presence

SomaLogic Company Life